Actinium Pharmaceuticals appoints chief medical officer
Essential IR Insights Newsletter Fall - 2023
A Corporation Clearly Pinpoints Activist Investor Activity
Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise
Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises
Actinium Pharmaceuticals Inc. tapped Mark Berger to replace Dragan Cicic as the company's chief medical officer.
Cicic was appointed to the newly created position of chief technology officer at the company.
Berger joins Actinium from Kadmon Corp., where he was senior vice president of clinical research.
